Moomoo AIのまとめ
On September 3, 2024, Intelligent Bio Solutions Inc., a Delaware-based company specializing in non-invasive drug testing technology, reported a significant 118% year-over-year growth in its customer employee base. The growth, detailed in a press release, indicates an increase of 720,000 employees from the previous fiscal year, bringing the total to an estimated 1.4 million employees across the company's global customer base. The average number of employees per new customer doubled compared to the previous year, reflecting the increased adoption of the company's Intelligent Fingerprinting Drug Screening System, particularly in high-risk industries such as Mechanical or Industrial Engineering, Construction, and Mining & Metals. The system is designed to ensure employees are fit for work by detecting recent illicit drug use. Harry Simeonidis, President and CEO of INBS, emphasized the importance of the technology in maintaining workplace safety. The company's commitment to expanding its reach and providing effective drug screening solutions was reiterated, with the growth in customer base serving as an indicator of the system's increased utilization.
On September 3, 2024, Intelligent Bio Solutions Inc., a Delaware-based company specializing in non-invasive drug testing technology, reported a significant 118% year-over-year growth in its customer employee base. The growth, detailed in a press release, indicates an increase of 720,000 employees from the previous fiscal year, bringing the total to an estimated 1.4 million employees across the company's global customer base. The average number of employees per new customer doubled compared to the previous year, reflecting the increased adoption of the company's Intelligent Fingerprinting Drug Screening System, particularly in high-risk industries such as Mechanical or Industrial Engineering, Construction, and Mining & Metals. The system is designed to ensure employees are fit for work by detecting recent illicit drug use. Harry Simeonidis, President and CEO of INBS, emphasized the importance of the technology in maintaining workplace safety. The company's commitment to expanding its reach and providing effective drug screening solutions was reiterated, with the growth in customer base serving as an indicator of the system's increased utilization.
2024年9月3日、テクノロジーで非侵襲性の薬物検査に特化したデラウェア州の企業、Intelligent Bio Solutions Inc.は、顧客の従業員数が前年比118%増の著しい成長を報告しました。プレスリリースで詳細に述べられた成長は、前の会計年度から72万人の従業員増加を示し、グローバルな顧客基盤で推定140万人の従業員をもたらしました。新規顧客あたりの平均従業員数は前年比で倍増し、特に機械工学や産業工学、建設、鉱業および金属業などのハイリスク産業で企業のIntelligent Fingerprinting Drug Screening Systemの採用が増加していることを反映し...すべて展開
2024年9月3日、テクノロジーで非侵襲性の薬物検査に特化したデラウェア州の企業、Intelligent Bio Solutions Inc.は、顧客の従業員数が前年比118%増の著しい成長を報告しました。プレスリリースで詳細に述べられた成長は、前の会計年度から72万人の従業員増加を示し、グローバルな顧客基盤で推定140万人の従業員をもたらしました。新規顧客あたりの平均従業員数は前年比で倍増し、特に機械工学や産業工学、建設、鉱業および金属業などのハイリスク産業で企業のIntelligent Fingerprinting Drug Screening Systemの採用が増加していることを反映しています。このシステムは、最近の違法薬物使用を検出することで従業員が適切に働けることを保証するよう設計されています。INBSの社長兼CEOであるHarry Simeonidis氏は、職場の安全性を維持する上でこのテクノロジーの重要性を強調しました。顧客基盤の成長は、システムの利用拡大の指標として、企業が事業領域を拡大し、効果的な薬物検査ソリューションを提供することへの取り組みが再確認されました。
役に立った
役に立たない
